Masashi Kondo
1252  results:
Search for persons X
?
3

How Much More Efficient Are Adaptive Platform Trials Than M..:

Sasaki, Masanao ; Sato, Hiroyuki ; Uemura, Yukari...
Clinical Pharmacology & Therapeutics.  115 (2024)  6 - p. 1372-1382 , 2024
 
?
4

It might be a dead end: immune checkpoint inhibitor therapy..:

Akao, Ken ; Oya, Yuko ; Sato, Takaya...
Exploration of Targeted Anti-tumor Therapy.  5 (2024)  4 - p. 826-840 , 2024
 
?
5

Correction to: Brigatinib in Japanese patients with tyrosin..:

Sugawara, Shunichi ; Kondo, Masashi ; Yokoyama, Toshihide...
International Journal of Clinical Oncology.  28 (2023)  5 - p. 724-725 , 2023
 
?
7

Favipiravir for symptomatic COVID-19: A nationwide observat..:

Doi, Yohei ; Ishihara, Takuma ; Banno, Sumi..
Journal of Infection and Chemotherapy.  29 (2023)  2 - p. 150-156 , 2023
 
?
13

Brigatinib in Japanese patients with tyrosine kinase inhibi..:

Sugawara, Shunichi ; Kondo, Masashi ; Yokoyama, Toshihide...
International Journal of Clinical Oncology.  27 (2022)  12 - p. 1828-1838 , 2022
 
?
15

Effectiveness of Favipiravir on Nonsevere, Early-Stage COVI..:

Tsuzuki, Shinya ; Hayakawa, Kayoko ; Doi, Yohei...
Infectious Diseases and Therapy.  11 (2022)  3 - p. 1075-1087 , 2022
 
1-15